Prostate tumor progression and prognosis: interplay of tumor and host factors

被引:13
作者
Harding, MA
Theodorescu, D [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Urol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA
来源
UROLOGIC ONCOLOGY | 2000年 / 5卷 / 06期
关键词
prostate neoplasms; biological tumor markers; prognosis; molecular cloning;
D O I
10.1016/S1078-1439(00)00073-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognosis for prostate cancer is largely dependent on the probability of metastatic dissemination. Prognostic markers currently in use are very poor predictors of metastatic potential, and as of yet none of the battery of new molecular markers has proven greatly superior. This may be due in part to their inability to assess the degree of interaction of subpopulations of prostate cancer cells with each ether and with their microenvironment. A growing body of evidence indicates that these types of interactions are a major factor in the eventual genesis of cancer cells capable of metastasis. Recent research has demonstrated that specialized components of prostate tumors may play a critical supporting role for the overall growth of the larger tumor. The multifocal nature and apparent polyclonal origins of prostate tumors suggest that carcinogenesis and tumor progression are promoted by global influences or "field effects." It appears that these effects extend beyond the proliferating epithelial component to the tissue stroma. Prostate cancer cells and stromal cells seem to act in concert to modify the microenvironment, leading to metastasis. An understanding of this synergy may provide a new class of prognostic markers which more accurately measure the complex set of interactions that determine tumor behavior. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 66 条
[1]  
Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO
[2]  
2-S
[3]  
Abrahamsson PA, 1998, PROSTATE, P37
[4]   Role of tumor vascular architecture in nutrient and drug delivery: An invasion percolation-based network model [J].
Baish, JW ;
Gazit, Y ;
Berk, DA ;
Nozue, M ;
Baxter, LT ;
Jain, RK .
MICROVASCULAR RESEARCH, 1996, 51 (03) :327-346
[5]  
Bostwick D G, 1999, Semin Urol Oncol, V17, P222
[6]  
Bostwick DG, 1998, CANCER, V83, P1995, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1995::AID-CNCR16>3.0.CO
[7]  
2-2
[8]   Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies [J].
Bostwick, DG ;
Wheeler, TM ;
Blute, M ;
Barrett, DM ;
MacLennan, GT ;
Sebo, TJ ;
Scardino, PT ;
Humphrey, PA ;
Hudson, MA ;
Fradet, Y ;
Miller, GJ ;
Crawford, ED ;
Blumenstein, BA ;
Mahran, HE ;
Miles, BJ .
UROLOGY, 1996, 48 (01) :47-57
[9]  
BRAWER MK, 1994, CANCER, V73, P678, DOI 10.1002/1097-0142(19940201)73:3<678::AID-CNCR2820730329>3.0.CO
[10]  
2-6